Erratum: An economic evaluation of aripiprazole vs olanzapine adapted to the Italian setting using outcomes of metabolic syndrome and risk for diabetes in patients with schizophrenia. Neuropsychiatr Dis Treat, 4: 967–976
ErratumColombo GL, Caruggi M, Di Matteo, et al. 2008. An economic evaluation of aripiprazole vs olanzapine adapted to the Italian setting using outcomes of metabolic syndrome and risk for diabetes in patients with schizophrenia. Neuropsychiatr Dis Treat, 4: 967–976.Page 972, Results, r...
Guardado en:
Autores principales: | Colombo GL, Caruggi M, Di Matteo, et al |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5ebb63c24da047e383dd2b549e53c10b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
An economic evaluation of aripiprazole vs olanzapine adapted to the Italian setting using outcomes of metabolic syndrome and risk for diabetes in patients with schizophrenia
por: Giorgio L Colombo, et al.
Publicado: (2008) -
Treatment and prevention of mania in bipolar I disorder: focus on aripiprazole
por: David J Muzina
Publicado: (2009) -
Incident Management for Explainable and Automated Root Cause Analysis in Cloud Data Centers    
por: Arnak Poghosyan, et al.
Publicado: (2021) -
Acta N°976
por: Banco Central de Chile
Publicado: (2021) -
Asenapine monotherapy in the acute treatment of both schizophrenia and bipolar I disorder
por: Delia Bishara, et al.
Publicado: (2009)